Form 4: Pfizer EVP Sahni Exercises Stock Appreciation Rights

Pfizer Executive Vice President Payal Sahni reported the earn-out and exercise of 56,888 stock appreciation rights, resulting in a net change in her direct common stock holdings.

Summary

• Payal Sahni, Executive Vice President of Pfizer Inc., exercised 56,888 Stock Appreciation Rights (SARs) on February 25, 2026.
• The SARs had an exercise price of $33.82 per share.
• In connection with the earn-out, 56,888 shares of common stock were acquired.
• 1,083 shares were withheld to satisfy tax obligations at a price of $27.09 per share.
• An additional 54,066 shares were withheld to cover the payment of the exercise price of the SARs at a price of $26.92 per share, based on the 20-day average closing price.
• Following these transactions, Sahni directly owns 27,667 shares of Pfizer common stock and indirectly owns 14,630 shares through a Rule 16b-3 Plan.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, as it reflects an executive realizing value from their compensation, which is a normal part of long-term incentive plans. It doesn't provide significant new information about the company's operational performance or future prospects.

Positives

• Executive Vice President Payal Sahni realized value from her compensation package by exercising 56,888 Stock Appreciation Rights.
• The transaction demonstrates the company's compensation structure is delivering value to its executives.

Negatives

• A significant portion of the acquired shares (54,066 shares) were immediately disposed of to cover the exercise price, and 1,083 shares for tax obligations, reducing the net increase in direct holdings.

Future Outlook

na

Industry Context

StockSavvy.ai notes that routine insider transactions like the exercise of stock appreciation rights are common across industries, particularly in mature companies like Pfizer, as part of executive compensation packages. These transactions reflect the vesting and monetization of long-term incentives rather than a strategic shift or market signal.

Related Party Transactions

• The transactions involve the exercise of stock appreciation rights granted by Pfizer Inc. to its Executive Vice President, Payal Sahni, which is a standard related-party compensation arrangement.

Stakeholder Impact

• Shareholders: The transaction is a routine compensation event and has minimal direct impact on existing shareholders beyond the slight dilution from new share issuance (if any, though here it's more about existing SARs).
• Employees: Demonstrates the company's executive compensation structure in action.
• Management: Payal Sahni has monetized a portion of her long-term incentives.

Key Dates

Keywords

Pfizer, PFE, Form 4, Insider Trading, Stock Appreciation Rights, Executive Compensation, Payal Sahni, Stock Transaction